Clinical trial
Efficacy of Platelet-Rich Plasma (PRP) in the Treatment of Periorbital Hyperpigmentation
NCT03114514 is registered in ClinicalTrials.gov with Damascus University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Platelet-Rich Plasma (PRP) in the Treatment of Periorbital Hyperpigmentation
- Lead sponsor
- Damascus University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 17, 2016
- Completion date
- May 10, 2017
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
periorbital hyperpigmentation